Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2017-07-03 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 87% confidence The text clearly describes the number of shares purchased under the company’s stock buyback program. This falls under the share repurchase/transaction in own shares category rather than a full financial report or mere publication notice.
2017-07-03 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased shares under a stock buyback program, detailing the number of shares and transaction value. This directly relates to the company acquiring its own stock. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is very short and directs the reader to a PDF, but the core content is a specific transaction report, making POS a more precise classification than RPA or RNS.
2017-06-26 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions under a 'stock buyback program' for Novozymes, providing accumulated figures and daily transaction details (number of shares, average price, transaction value) for the period of June 19 to June 23, 2017. This content directly relates to the company managing its own shares through repurchase activities. According to the definitions, this aligns perfectly with the 'Transaction in Own Shares' category (Code: POS). The document is a detailed report/announcement of these transactions, not just a notice that a report is available (which would suggest RPA or RNS).
2017-06-26 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement from Novozymes A/S regarding transactions related to its share buy-back program. It includes specific data on the number of shares repurchased, transaction values, dates, and compliance with EU market abuse regulations. The content focuses on the company's repurchase of its own shares, providing detailed transactional data and regulatory references. There is no indication of financial results, management commentary, or other report types. The document is not a report itself but an announcement of share repurchase transactions. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence in this classification.
2017-06-26 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 95% confidence The text describes the company’s purchase of its own shares under a buyback program (number of shares and transaction value) and directs readers to the full announcement. This is a Transaction in Own Shares announcement, matching code POS.
2017-06-26 Danish
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly relates to the company acquiring its own shares. The most specific category for this activity is 'Transaction in Own Shares' (POS). Although it mentions reading the full announcement in PDF, the core content is the transaction update, making POS more appropriate than RPA or RNS, given the specific nature of the update.
2017-06-19 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.